Modern Pediatrics. Ukraine. (2023). 7(135): 105-112. doi 10.15574/SP.2023.135.105
Boyarchuk O. R., Kovalchuk N. I., Benediuk T. O., Dobrovolska L. I.
I. Horbachevsky Ternopil National Medical University, Ukraine

For citation: Boyarchuk OR, Kovalchuk NI, Benediuk TO, Dobrovolska LI. (2023). Role of vitamin D in juvenile idiopathic arthritis. Modern Pediatrics. Ukraine. 7(135): 105-112. doi: 10.15574/SP.2023.135.105.
Article received: Aug 31, 2023. Accepted for publication: Nov 18, 2023.

Considering the role of vitamin D in mineral metabolism and its extracellular effects, including immunomodulation with a tendency to suppress the immune response, there is significant interest in determining its role in developing autoimmune diseases, including juvenile idiopathic arthritis (JIA).
Purpose – to determine the role of vitamin D in the development and course of JIA based on a systematic analysis of literature sources over the last 7 years. A search was conducted on PubMed for articles on the role of vitamin D in the development and course of JIA, using combinations of the following terms: “vitamin D” and “juvenile idiopathic arthritis”. The review included scientific publications with available full texts published from January 2017 to August 2023.
The analysis results showed significant variations in the level of 25(OH)D among patients with JIA, and the vitamin D status in the majority of JIA patients was not optimal. However, the percentage of patients with suboptimal levels and vitamin D deficiency, according to the majority of studies, was not more significant than in the general population. Nevertheless, a correlation was found between low 25(OH)D concentration and high activity of JIA. Additional vitamin D supplementation did not impact the reduction of JIA activity or the improvement of indicators of bone mineral density. However, some publications emphasize the positive effect of sun exposure in reducing the risk of JIA. Further research is needed to clarify the necessity of additional vitamin D supplementation involving a larger number of patients, standardization, selection of optimal doses, and treatment duration.
No conflict of interests was declared by the authors.
Keywords: juvenile idiopathic arthritis, vitamin D, disease activity, development risk.

REFERENCES

1. Barut K, Adrovic A, Şahin S, Kasapçopur Ö. (2017). Juvenile Idiopathic Arthritis. Balkan Med J. 34(2): 90-101. https://doi.org/10.4274/balkanmedj.2017.0111; PMid:28418334 PMCid:PMC5394305

2. Boyarchuk O, Dobrovolska L, Svystunovych H. (2022). Selective immunoglobulin A deficiency in children with diabetes mellitus: Data from a medical center in Ukraine. PLoS One. 17(11): e0277273. https://doi.org/10.1371/journal.pone.0277273; PMid:36395204 PMCid:PMC9671439

3. Boyarchuk O, Kovalchuk T, Kovalchuk N, Chubata O. (2020). Clinical variability of the systemic juvenile idiopathic arthritis course: literature review based on case series. Reumatologia. 58(6): 436-443. https://doi.org/10.5114/reum.2020.102010; PMid:33456087 PMCid:PMC7792539

4. Boyarchuk O, Kuka A, Yuryk I. (2022). Clinical and autoantibody phenotypes of juvenile dermatomyositis. Reumatologia. 60(4): 281-291. https://doi.org/10.5114/reum.2022.119045; PMid:36186835 PMCid:PMC9494788

5. Boyarchuk O, Predyk L, Yuryk I. (2021). COVID-19 in patients with juvenile idiopathic arthritis: frequency and severity. Reumatologia. 59(3): 197-199. https://doi.org/10.5114/reum.2021.107590; PMid:34538947 PMCid:PMC8436806

6. Boyarchuk OR, Dobrovolska LI, Kinash MI et al. (2019). Survey assesment of vitamin D and calcium dietary intake in children with somatic pathology. Vopr Pitan. 88(5): 53-62. doi: 10.24411/0042-8833-2019-10054.

7. Cetrelli L, Bletsa A, Lundestad A et al. (2022). Vitamin D, oral health, and disease characteristics in juvenile idiopathic arthritis: a multicenter cross-sectional study. BMC Oral Health. 22(1): 333. https://doi.org/10.1186/s12903-022-02349-1; PMid:35941635 PMCid:PMC9361556

8. Charuvanij S, Malakorn H, Densupsoontorn N, Nakavachara P. (2023). Bone Mineral Density and Serum 25OHD in Children and Adolescents With Juvenile Idiopathic Arthritis. Clin Pediatr (Phila). 62(5): 456-465. https://doi.org/10.1177/00099228221136982; PMid:36366793

9. Chiaroni-Clarke RC, Munro JE, Pezic A et al. (2019). Association of Increased Sun Exposure Over the Life-course with a Reduced Risk of Juvenile Idiopathic Arthritis. Photochem Photobiol. 95(3): 867-873. https://doi.org/10.1111/php.13045; PMid:30378692

10. Clarke SLN, Mitchell RE, Sharp GC, Ramanan AV, Relton CL. (2023). Vitamin D Levels and Risk of Juvenile Idiopathic Arthritis: A Mendelian Randomization Study. Arthritis Care Res (Hoboken). 75(3): 674-681. https://doi.org/10.1002/acr.24815; PMid:34748291

11. Cutolo M, Pizzorni C, Sulli A. (2011). Vitamin D endocrine system involvement in autoimmune rheumatic diseases. Autoimmun Rev. 11: 84-87. https://doi.org/10.1016/j.autrev.2011.08.003; PMid:21864722

12. Finch SL, Rosenberg AM, Kusalik AJ et al. (2021). Higher concentrations of vitamin D in Canadian children with juvenile idiopathic arthritis compared to healthy controls are associated with more frequent use of vitamin D supplements and season of birth. Nutr Res. 92: 139-149. https://doi.org/10.1016/j.nutres.2021.05.007; PMid:34311227

13. Finch SL, Rosenberg AM, Vatanparast H. (2018). Vitamin D and juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 16(1): 34. https://doi.org/10.1186/s12969-018-0250-0; PMid:29769136 PMCid:PMC5956785

14. Grober U, Spitz J, Reichrath J, Kisters K, Holick MF. (2013). Vitamin D: Update 2013: From rickets prophylaxis to general preventive healthcare. Dermatoendocrinology. 5: 331-347. https://doi.org/10.4161/derm.26738; PMid:24516687 PMCid:PMC3908963

15. Hillman LS, Cassidy JT, Chanetsa F, Hewett JE, Higgins BJ, Robertson JD. (2008). Percent true calcium absorption, mineral metabolism, and bone mass in children with arthritis: Effect of supplementation with vitamin D3 and calcium. Arthritis Rheum. 58: 3255-3263. https://doi.org/10.1002/art.23809; PMid:18821668

16. Holick MF. (2012). Vitamin D: Extraskeletal Health. Rheum Dis Clin N Am. 38: 141-160. https://doi.org/10.1016/j.rdc.2012.03.013; PMid:22525849

17. Kinash MI, Boyarchuk OR. (2020). Fat-soluble vitamins and immunodeficiency: mechanisms of influence and opportunities for use. Vopr Pitan. 89 (3): 22-32. doi: 10.24411/0042-8833-2020-10026.

18. Kovalchuk T, Boyarchuk O. (2023). Serum Vitamin D Levels in Children and Adolescents with Vasovagal Syncope, Syncope Due to Orthostatic Hypotension, and Cardiac Syncope. Turk Arch Pediatr. 58(1): 42-48. https://doi.org/10.5152/TurkArchPediatr.2022.22141; PMid:36598210 PMCid:PMC9885808

19. Marini F, Falcini F, Stagi S et al. (2020). Study of vitamin D status and vitamin D receptor polymorphisms in a cohort of Italian patients with juvenile idiopathic arthritis. Sci Rep. 10(1): 17550. https://doi.org/10.1038/s41598-020-74861-9; PMid:33067526 PMCid:PMC7567873

20. Marushko YuV, Hyshchak TV. (2021). Prevention of vitamin D deficiency in children. The state of the proble in the world and in Ukraine. Modern Pediatrics. Ukraine. 4(116): 36-45. https://doi.org/10.15574/SP.2021.116.36

21. Mochulska OM, Boyarchuk OR, Kinash MI, Shulhai OM, Dobrovolska LI. (2022). Vitamin status as an assessment of vitamins A, E, D providing in children with allergic dermatosis. Modern Pediatrics. Ukraine. 6(126): 55-61. https://doi.org/10.15574/SP.2022.126.55

22. Nandi M, Mullick MAS, Nandy A, Samanta M, Sarkar S, Sabui TK. (2022). Evaluation of vitamin D profile in juvenile idiopathic arthritis. Mod Rheumatol. 32(4): 792-796. https://doi.org/10.1093/mr/roab053; PMid:34910210

23. Nisar MK, Masood F, Cookson P, Sansome A, Ostör AJK. (2013). What do we know about juvenile idiopathic arthritis and vitamin D? A systematic literature review and meta-analysis of current evidence. Clin Rheumatol. 32: 729-734. https://doi.org/10.1007/s10067-012-2159-1; PMid:23296646

24. Płudowski P, Karczmarewicz E, Bayer M et al. (2013). Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe – recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol Pol. 64(4): 319-27. https://doi.org/10.5603/EP.2013.0012; PMid:24002961

25. Płudowski P, Kos-Kudła B, Walczak M et al. (2023). Guidelines for Preventing and Treating Vitamin D Deficiency: A 2023 Update in Poland. Nutrients. 15(3): 695. https://doi.org/10.3390/nu15030695; PMid:36771403 PMCid:PMC9920487

26. Rezaei E, Hogan D, Trost B, et al. (2020). Clinical and associated inflammatory biomarker features predictive of short-term outcomes in non-systemic juvenile idiopathic arthritis. Rheumatology (Oxford). 59(9): 2402-2411. https://doi.org/10.1093/rheumatology/kez615; PMid:31919503 PMCid:PMC7449798

27. Rooney M, Bishop N, Davidson J, et al; British Society for Paediatric and Adolescent Rheumatology UK. (2019). The prevention and treatment of glucocorticoid-induced osteopaenia in juvenile rheumatic disease: A randomised double-blind controlled trial. EClinicalMedicine. 12: 79-87. https://doi.org/10.1016/j.eclinm.2019.06.004; PMid:31388666 PMCid:PMC6677647

28. Sabbagh Z, Markland J, Vatanparast H. (2013). Vitamin D status is associated with disease activity among rheumatology outpatients. Nutrients. 5: 2268-2275. https://doi.org/10.3390/nu5072268; PMid:23803739 PMCid:PMC3738972

29. Sengler C, Zink J, Klotsche J, et al. (2018). Vitamin D deficiency is associated with higher disease activity and the risk for uveitis in juvenile idiopathic arthritis – data from a German inception cohort. Arthritis Res Ther. 20(1): 276. https://doi.org/10.1186/s13075-018-1765-y; PMid:30545399 PMCid:PMC6293517

30. Shevchenko N, Khadzhynova Y. (2019). Juvenile idiopathic arthritis and vitamin d status in ukrainian patients. Georgian Med News. (294): 88-91.

31. Stagi S, Bertini F, Cavalli L, Matucci-Cerinic M, Brandi ML, Falcini F. (2014). Determinants of vitamin D levels in children, adolescents, and young adults with juvenile idiopathic arthritis. J Rheumatol. 41: 1884-1892. https://doi.org/10.3899/jrheum.131421; PMid:25086083

32. Stawicki MK, Abramowicz P, Góralczyk A, Młyńczyk J, Kondratiuk A, Konstantynowicz J. (2022). Prevalence of Vitamin D Deficiency in Patients Treated for Juvenile Idiopathic Arthritis and Potential Role of Methotrexate: A Preliminary Study. Nutrients. 14(8): 1645. https://doi.org/10.3390/nu14081645; PMid:35458206 PMCid:PMC9027140

33. Stawicki MK, Abramowicz P, Sokolowska G, Wołejszo S, Grant WB, Konstantynowicz J. (2023). Can vitamin D be an adjuvant therapy for juvenile rheumatic diseases? Rheumatol Int. 2023 Aug 11. https://doi.org/10.1007/s00296-023-05411-5; PMid:37566255 PMCid:PMC10495493

34. Sumi SK, Rahman SA, Islam MI, Islam MM, Talukder MK. (2020). Vitamin D Profile in Juvenile Idiopathic Arthritis Patients in a Tertiary Care Hospital in Bangladesh. Mymensingh Med J. 29(2): 311-316. PMID: 32506084.

35. Tang T, Zhang Y, Luo C, Liu M, Xu L, Tang X. (2019). Adjunctive vitamin D for the treatment of active juvenile idiopathic arthritis: An open-label, prospective, randomized controlled trial. Exp Ther Med. 18: 4921-4926. https://doi.org/10.3892/etm.2019.8133

36. Thorsen SU, Pipper CB, Alberdi-Saugstrup M et al. (2017). No association between vitamin D levels around time of birth and later risk of developing oligo- and polyarticular juvenile idiopathic arthritis: a Danish case-cohort study. Scand J Rheumatol. 46(2): 104-111. https://doi.org/10.1080/03009742.2016.1178325; PMid:27460412

37. Volianska L, Burbela E, Kosovska T, Perestyuk V, Boyarchuk O. (2023). The role of vitamin D in the course of SARS-CoV-2 infection and long COVID in children (literature review). Child's health. 18(3): 225-230. https://doi.org/10.22141/2224-0551.18.3.2023.1590

38. Von Scheven E, Burnham JM. (2011). Vitamin D supplementation in the pediatric rheumatology clinic. Curr Rheumatol Rep. 13: 110-116. https://doi.org/10.1007/s11926-010-0161-7; PMid:21221865 PMCid:PMC3092921

39. Wu CY, Yang HY, Luo SF, Huang JL, Lai JH. (2022). Vitamin D Supplementation in Patients with Juvenile Idiopathic Arthritis. Nutrients. 14(8): 1538. https://doi.org/10.3390/nu14081538; PMid:35458099 PMCid:PMC9029755